The Heat-Stable Agent of Heredity

The glass rod lifted from the cold alcohol bath trailing a single, glistening filament. It looked like the sheerest spider silk, a wet, white thread that thickened as it rose, coiling upon itself until it formed a small, gelatinous knot at the end of the rod. In the quiet laboratory on the sixth floor of the Rockefeller Institute Hospital, this delicate operation—precipitating the active extract from a solution of heat-killed bacteria—had been repeated hundreds of times.

Each repetition was a step in a monumental act of purification. The man holding the rod, Oswald Avery, was in his late sixties, a small, precise bacteriologist who spoke softly and published rarely. For over a decade, he and his younger colleagues, Colin MacLeod and Maclyn McCarty, had been closing in on the substance that now clung to the glass. They were not chasing a theory. They were isolating a fact. Someone had to take the slurry from a heat-killed bacterium and break it down, component by chemical component, to find which one held the transformative power.

The purification itself was a feat of industrial-scale biochemistry, a marriage of delicate precision and brute-force processing. The team began with seventy-five-liter batches of virulent Type III pneumococci, grown in vast vats of beef-heart broth. These cultures were then heat-killed, a process that preserved the transforming principle Griffith had identified but rendered the bacteria inert. The first challenge was to break open these billions of tiny cellular casings to release their contents. This was achieved through a combination of chemical agents and physical disruption—washing the cells in saline, treating them with bile salts to dissolve their membranes, and repeatedly freezing and thawing the resulting slurry to mechanically shear the remnants. What remained was a thick, opaque soup of bacterial debris: shattered cell walls, fragmented organelles, and a complex mixture of every biochemical the pneumococcus contained. From this murky starting point, Avery, MacLeod, and McCarty began their relentless subtraction.

Their guiding principle was solubility. By exploiting the different chemical behaviors of cellular components in various solvents, they could sequentially strip away unwanted material. The crude extract was first treated with chloroform, which denatured and removed much of the protein, creating a frothy emulsion that could be centrifuged away. The remaining aqueous solution was then mixed with ethanol and chilled. In the cold, long-chain molecules like nucleic acids and polysaccharides lose their solubility and fall out of solution. It was at this stage that the “glistening filament” would appear—the fibrous precipitate that, when wound onto a glass rod, represented a fraction immensely enriched in transforming activity.

But this was only a preliminary concentration. To achieve true purity, the team turned to more sophisticated techniques, repeatedly redissolving the precipitate and subjecting it to further rounds of alcohol fractionation at carefully controlled pH levels and salt concentrations. Each cycle discarded more inert material, gradually winnowing the active principle from the biochemical chaff.

The work exhausted them. McCarty, the biochemist of the trio, later recalled the “sheer drudgery” of these procedures, which could consume weeks for a single batch. Yet every step was necessary, for their ultimate goal was not merely to isolate an active fraction, but to subject that fraction to a battery of chemical tests that would reveal its fundamental nature. They needed a preparation so pure that its activity could be unambiguously linked to a single class of molecule. By 1943, after years of optimization, they had it: a white, fibrous powder that was astonishingly potent. A solution containing just one part of this purified material in six hundred million parts of saline could still permanently transform harmless Type II pneumococci into the virulent, capsulated Type III form. This incredible biological potency was the first major clue that they were dealing with something extraordinary.

With the purified transforming principle in hand, the team began their systematic process of elimination. The prevailing assumption, of course, was that the active agent was a protein. Their first task was to dismantle this hypothesis with direct experimental evidence. They subjected their purified extract to a arsenal of protein-destroying agents.

They treated it with potent proteolytic enzymes like trypsin and chymotrypsin, which cleave the peptide bonds between amino acids. They boiled it in strong acid and strong alkali, conditions that utterly denature and hydrolyze protein chains. In every case, they recovered the extract, reassayed it, and found its transforming power undiminished.

The activity survived conditions that would reduce the most robust enzyme to a non-functional tangle. This was a profound result, but Avery, ever cautious, knew it was not yet conclusive. It was possible, however unlikely, that a special, resistant type of protein could survive such onslaughts. The team needed to complement these destructive tests with positive chemical analysis.

They therefore performed a direct elemental assay on their purest samples. Proteins, rich in nitrogen and sulfur, have characteristic ratios of these elements to carbon and hydrogen. The chemical analysis of the transforming principle, however, revealed a composition that matched not protein, but nucleic acid. The nitrogen-to-phosphorus ratio was particularly telling. Furthermore, standard colorimetric tests for specific amino acids—the building blocks of proteins—came back negative or showed only trace contamination. The positive tests were for deoxyribose sugar and for purine and pyrimidine bases, the hallmarks of DNA. The chemical fingerprint pointed decisively away from protein. Concurrently, they ruled out other major cellular constituents. Lipid solvents failed to remove the activity. Treatments with enzymes that specifically break down the complex polysaccharide of the pneumococcal capsule, or with other carbohydrate-digesting enzymes, likewise left the transforming principle intact. One by one, the logical alternatives were checked and discarded.

The climax of their investigation, the definitive negative proof, came from the use of highly specific enzymes. This was the masterstroke of biochemical logic. If the transforming activity was due to DNA, then an enzyme that selectively degraded DNA should destroy it, while enzymes that attacked other substrates should not. McCarty took the lead in sourcing and testing these biological tools. He obtained a preparation of an enzyme called deoxyribonuclease (DNase), which had only recently been characterized. This enzyme specifically catalyzes the breakdown of deoxyribonucleic acid, snipping the long chains into small fragments, but

The team’s methodology was a masterpiece of systematic doubt. Each biochemical test was not merely a procedure but a deliberate strike against the reigning orthodoxy. When they applied proteolytic enzymes, they were not just degrading proteins; they were challenging the central dogma of biochemical complexity.

The survival of the transforming principle after such treatment was a quiet but seismic anomaly. Avery, with his ingrained caution, insisted on redundancy. They didn’t rely on a single enzyme or one harsh chemical treatment; they deployed a cascade of them, each attack designed from a different angle to annihilate any conceivable protein structure. The fact that the activity emerged unscathed every time forced a slow, reluctant conclusion: the molecule they sought was not a protein.

This negative evidence, however compelling, was only half the battle. To convince a skeptical field, they needed to couple it with positive identification.

The elemental analysis and colorimetric tests provided that crucial link. The absence of sulfur and the specific nitrogen-to-phosphorus ratio were not abstract numbers; they were chemical fingerprints that pointed unerringly toward a nucleic acid. In the quiet of their lab, data was accumulating into a portrait that contradicted everything textbooks asserted about the machinery of inheritance.

The definitive experiment with deoxyribonuclease was the culmination of this painstaking process. McCarty’s acquisition of a sufficiently pure DNase preparation was itself a critical hurdle, as the enzyme was a relatively novel biochemical tool. The design was elegantly simple: divide the purified transforming principle into two samples. To one, add the DNase. To the other, add an inactivated form of the same enzyme, as a control.

Then, after incubation, test both samples for their power to transform harmless pneumococci. The logic was inexorable. If DNA was the active substance, the DNase-treated sample would lose all potency while the control remained active. And so it proved. The enzyme that specifically disassembled DNA chains, and only that enzyme, abolished the transforming activity completely.

This was not merely another piece of correlative evidence; it was a direct causal demonstration. Destroy this specific molecule, and you destroy heredity’s chemical messenger. The transformation was not just associated with DNA; it was dependent on it. This experiment closed the logical loop, transforming a chain of suggestive evidence into a watertight biochemical proof.

Yet, for all its internal rigor, the team was acutely aware of the conceptual leap their work implied. Avery, in particular, was haunted by the possibility of an undetectable protein contaminant, a specter that the protein-centric worldview made seem plausible no matter how pure his preparations seemed. In his correspondence, he voiced this nagging doubt, even as his own data rendered it increasingly irrational.

This personal skepticism mirrored the broader institutional resistance they would face. The scientific establishment’s commitment to proteins was not merely a mistaken hypothesis; it was a fully realized paradigm with deep explanatory roots. Since the early 20th century, biologists had convincingly argued that genes must be complex enough to specify life’s staggering diversity. Proteins, with their 20 different amino acids capable of near-infinite permutations, perfectly fit that requirement. They were the dynamic actors in the cell, catalyzing reactions and building structures. It seemed only logical that they would also be the archivists.

DNA, on the other hand, was dismissed as a “stupid molecule.” The tetranucleotide hypothesis, then influential, proposed that DNA was a simple, repeating polymer of just four nucleotides—a monotonous scaffold utterly lacking the informational variety needed to be the stuff of genes. Avery’s evidence directly contradicted this comfortable assumption, but paradigms do not fall on evidence alone.

The reception of their landmark 1944 paper in the Journal of Experimental Medicine revealed this entrenched resistance. While some astute researchers, like Alfred Mirsky—a protein expert and Avery’s colleague at Rockefeller—immediately grasped the implications, many more responded with caution or outright dismissal. Critics latched onto Avery’s own cautious phrasing. He had written that the evidence “suggested” DNA was the transforming principle, not that it definitively was the gene. Skeptics argued that perhaps the DNA was merely a structural carrier for an elusive, undetectable protein that was the true active agent.

Others questioned whether a phenomenon observed in bacteria could possibly apply to the genetics of higher organisms. The resistance was not necessarily illogical; it was protective of an entire framework of understanding. Accepting Avery’s conclusion required not just acknowledging a new fact, but dismantling a foundational pillar of biology. It demanded a conceptual revolution that few were ready to make based on a single, albeit exquisite, bacterial system.

Within the laboratory, however, the weight of the discovery was palpable. McCarty later recalled the profound sense of significance that settled over them once the DNase experiment was complete. They understood they had not simply solved a technical puzzle in bacteriology; they had laid hands on the physical basis of heredity. The “heat-stable agent” was now a chemical entity: deoxyribonucleic acid.

This realization set in motion a new and urgent set of questions. If DNA was the substance of genes, how did it work? How could a molecule presumed to be chemically monotonous carry such vast and specific instructions? The very properties that had led to its dismissal now constituted the central mystery. Avery’s team had provided the answer to “what,” but in doing so, they had unleashed the far more difficult question of “how.”

Their work created a pivot point, redirecting the trajectory of biological research from the chemistry of proteins toward the structure and function of nucleic acids. The ghostly filament on the glass rod was no longer just a purified bacterial extract; it was a thread leading into the deepest mysteries of life itself, waiting for the next generation of scientists to follow.